Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D06QIW
|
||||
Former ID |
DIB004576
|
||||
Drug Name |
EPO peptide mimetics
|
||||
Synonyms |
HemoMer; SESTide; AGE-49C; AGE-53C; EPO peptide mimetics (anemia); AG-EM-0040; EPO peptide mimetics (anemia), AplaGen; Erythropoietin peptide mimetics (anemia), AplaGen
|
||||
Indication | Anemia [ICD9: 280-285; ICD10:D50-D64] | Investigative | [543465] | ||
Company |
AplaGen GmbH
|
||||
Target and Pathway | |||||
Target(s) | Erythropoietin Receptor | Target Info | Modulator | [543465] | |
NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
Pathway Interaction Database | Signaling events mediated by Stem cell factor receptor (c-Kit) | ||||
EPO signaling pathway | |||||
WikiPathways | EPO Receptor Signaling | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.